Evidence map›Paper›PMID 25581900›Full record

ArticleJournal of cellular biochemistry2015

Pyrosequencing for accurate imprinted allele expression analysis.

Bing Yang, Nathan Damaschke, Tianyu Yao, Johnathon McCormick, Jennifer Wagner, David Jarrard

Abstract read
In one paragraph

Article in Journal of cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Detecting Azole-Antifungal Resistance inJournal of fungi (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bing YangDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Nathan DamaschkeDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Tianyu YaoDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Johnathon McCormickDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Jennifer WagnerDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
David JarrardDepartment of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
University of Wisconsin–Madison · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
MODULATION OF IGF-II IMPRINTING IN THE AGING PROSTATER01CA097131 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI JARRARD, DAVID F. · 2002 to 2013
$2.5M
Modulation Of IGF-II Imprinting in the Aging ProstateR56CA097131 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI JARRARD, DAVID F. · 2008 to 2008
$250k
NCI NIH HHS 5R01CA097131NCI NIH HHS R01 CA097131NCI NIH HHS R56 CA097131NCI NIH HHS T32 CA009135
6 · The paper itself

Abstract

Genomic imprinting is an epigenetic mechanism that restricts gene expression to one inherited allele. Improper maintenance of imprinting has been implicated in a number of human diseases and developmental syndromes. Assays are needed that can quantify the contribution of each paternal allele to a gene expression profile. We have developed a rapid, sensitive quantitative assay for the measurement of individual allelic ratios termed Pyrosequencing for Imprinted Expression (PIE). Advantages of PIE over other approaches include shorter experimental time, decreased labor, avoiding the need for restriction endonuclease enzymes at polymorphic sites, and prevent heteroduplex formation which is problematic in quantitative PCR-based methods. We demonstrate the improved sensitivity of PIE including the ability to detect differences in allelic expression down to 1%. The assay is capable of measuring genomic heterozygosity as well as imprinting in a single run. PIE is applied to determine the status of Insulin-like Growth Factor-2 (IGF2) imprinting in human and mouse tissues.

Indexed as

Genomic ImprintingAllelesAnimalsGene Expression ProfilingHeterozygoteHigh-Throughput Nucleotide SequencingHumansInsulin-Like Growth Factor IIMaleMicePolymorphism, Single NucleotideProstateSensitivity and SpecificitySequence Analysis, DNAInsulin-Like Growth Factor IIEPIGENETICIGF2IMPRINTINGINTRON-CROSSING PRIMERPYROSEQUENCING

Identifiers

PMID25581900
PMCPMC4880354
OpenAlexW2051018947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.